LexDanaLexDanabeta
Inventor

Tom Miller

Inventor
Wakefield, MA, US

Overview

6→
Patents
2018–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes19%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
PatentTitleYear
10,865,206Inhibitors of cyclin-dependent kinase 7 (CDK7)202010,519,135Inhibitors of cyclin-dependent kinase 7 (CDK7)201910,308,648Inhibitors of cyclin-dependent kinase 7 (CDK7)201910,106,526Inhibitors of cyclin-dependent kinase 7 (CDK7)201810,059,690Inhibitors of cyclin-dependent kinase 7 (CDK7)201810,047,070Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2020Patents assigned to SYROS PHARMACEUTICALS INC (5)· patent assignee history
2018Patents assigned to DANA FARBER CANCER INST INC (1)· patent assignee history
2018–2020Based in Wakefield, MA, US· patent location history
2018Based in Wakefiled, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SYROS PHARMACEUTICALS INC52018–2020
DANA FARBER CANCER INST INC12018
Locations
LocationPatentsSpan
Wakefield, Massachusetts, US52018–2020
Wakefiled, Massachusetts, US12018